Wednesday, July 22, 2026

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

Inside North Korea’s Flood Recovery: How Volunteers and Youth are Leading the Charge

North Korea continues its all-out efforts to recover from the flood damage caused by recent heavy rains in the Yalu River area.

Unlocking North Korea: How Smartphones Are Transforming Life Under Kim Jong Un

A new book explores North Korea's mobile technology, revealing how the regime uses it for control and modernization amid challenges.

Tag: bipolar disorder

Is ChatGPT to Blame? Man Sues OpenAI Over Mental Health Crisis Linked to AI Interaction

A man sues OpenAI, claiming ChatGPT worsened his bipolar disorder and led to a suicide attempt, highlighting AI's mental health risks.

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us